Profiles of IFCC Corporate Members

 A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacturing and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries. Abbott Diagnostics is a global leader in in vitro diagnostics and offers a broad range of innovative instrument systems and tests for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics. Abbott's diagnostic solutions offer customers automation, convenience, bedside testing, cost effectiveness and flexibility.
Website: www.abbott.com

ADx NeuroSciences

ADx NeuroSciences is a R&D company committed to improving the diagnosis of Alzheimer's disease & dementia. The company identifies and develops novel biomarkers for accurate diagnosis and the effective treatment and follow-up of patients suffering from Alzheimer's, Parkinson's and other neurodegenerative diseases.
Website: www.adxneurosciences.com

Agappe Diagnostics Ltd.

Manufacturers of complete range Diagnostic Reagents like Biochemistry kits, Serology, Immuno Turbidometry, Coagulation, Hematology Reagents and system packs for Biolis series. Products carry CE Marking. ISO 9001-2008 and 13485 - 2003 certified company. Also deals in a range of Fully Auto and Semi Auto Analyzers for various applications. We are exclusive distributors for world famous brands Like Tokyo Boeki Biolis Series and Mindray.
Web site: www.agappe.com

Analis R&D Diag

For more than 25 years, the "ANALIS R&D Diag", group specialized in electrophoresis, has developed kits for in vitro diagnostic, which have been distributed throughout the world. As a result of our long experience in designing kits for electrophoresis using agarose gels, Analis has developed kits for Capillary Electrophoresis. CEofix™ kits for Capillary Electrophoresis presented here are for Clinical Routine as well as Clinical Research:

  • Carbohydrate Deficient Transferrin kit is used to detect AUD (alcohol use disorder). The same kit has been used for Congenital Disorder of Glycosylation (CDG) and for transferrin in Cerebrospinal Fluid (CSF). This kit is FDA device listed and has CE-IVD label for Europe.
  • Hemoglobin analysis including variant analysis is possible using two buffer systems (alkaline and basic). The hemoglobin kits are CE-IVD labeled for Europe.
  • More generic buffers are also available which allow analysis of proteins for example in CSF or for peptides such as glutathione (GSH-GSSG) in blood.
  • Anions, organic acids or cations may also be analyzed using specific applications.
  • And a special dynamic coating may be used to facilitate CE-MS applications for proteome biomarker.

"R&D Diag" is composed of highly trained people, who offer assistance including running customer samples. We welcome ideas and projects in developing new applications using the high resolution power of Capillary Electrophoresis.
Website: http://www.analis.com/ and  http://ceofix.analis.be

Asahi Kasei Pharma Corporation

Asahi Kasei Pharma is the core operating company for all operations of the Asahi Kasei Group which serve the health care industries. The product range includes pharmaceuticals, medical devices, pharmaceutical intermediates, diagnostic reagents, nutritional products, and animal health products.
The Diagnostics Department develops and manufactures enzymes for clinical chemistry use, reagents, diagnostic kits, and human enzyme calibrator for standardization, employing state-of-the-art biotechnology, for marketing to reagent manufacturers, OEM reagent manufacturers, and hospital and commercial laboratories. Our focus is on value-added, continuous innovation and quality improvement of enzymes and enzyme-related products to meet the increasing demands for greater measurement accuracy and product-handling flexibility in the clinical chemistry marketplace.
Website: http://www.asahi-kasei.co.jp/asahi/en/index.html

Axis-Shield Point of Care Division AS

Axis-Shield is an innovative Anglo-Norwegian company focused on the development and manufacture of important in vitro diagnostic (IVD) tests for use in clinical laboratories and at the point of care. The Group comprises a Point-of-Care Division in Oslo, a Laboratory Division in Dundee and local distribution subsidiaries in the UK (Axis-Shield UK), in Norway, Sweden, Denmark and Finland (Medinor), in Switzerland (Axis-Shield AG) and in Germany (Axis-Shield GmbH) and most of these companies also sell third-party products and non-IVD medical devices. We also have a representative office in China and a growing organisation in the USA which is primarily charged with accelerating the Afinion placement programme.
At the point of care, our products include the NycoCard range and the Afinion. In the laboratory sector we specialise in proprietary markers for the early diagnosis and management of critical illnesses such as cardiovascular and neurodegenerative diseases, rheumatoid arthritis and diabetes. We are playing an increasingly leading role in the fight against the global diabetes epidemic, and the need to keep tight control over blood glucose levels to avoid serious clinical sequelae.
Website: http://www.axis-shield.com/ 

BD Diagnostics

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit http://www.bd.com/ 

Beckman Coulter, Inc.

Improving Patient Health and Reducing the Cost of Care
Beckman Coulter is an organization with one of the most comprehensive product portfolios in both life sciences and clinical diagnostics. When laboratories choose Beckman Coulter as their partner, they receive distinct advantages: a legacy of quality, superior brand equity, and a highly capable team of professionals with a single focus - making laboratories more efficient and productive. We are able to design, develop, manufacture, sell and support testing systems that simplify and automate complex biomedical testing.
Our customers include hospitals, physicians' offices, diagnostic reference laboratories, pharmaceutical and biotechnology companies, universities, medical schools and research institutions. In fact, Beckman Coulter has placed more than 200,000 clinical and research instrument systems in laboratories around the world.Our diagnostic systems are found in hospitals and other critical care settings around the world and produce information used by physicians to diagnose disease, make treatment decisions and monitor patients.

  • Instruments for life science research are used by scientists as they study the causes of disease, identify new therapies, and test new drugs.

Headquartered in Orange County, California, Beckman Coulter employs about 12,000 people worldwide, operating in more than 50 sites on six continents.
By offering laboratories the tools that increase the accuracy of test results and velocity of decision-making, Beckman Coulter is dedicated to improving patient health and reducing the cost of care.
Website: http://www.beckmancoulter.com/

The Binding Site Group Ltd.

Binding Site is a British-based company specialising in the research, development and production of immunodiagnostic kits and reagents. Binding Site manufactures a wide range of high quality and innovative products used in clinical laboratories world-wide. International support is provided in the UK, USA, Canada, Germany, Austria, France and Spain from Binding Site offices and a network of distributors in over 60 other countries.
The origins of the company go back to the early 1960's when antisera were produced to meet the needs of the Immunology department within the University of Birmingham Medical School. The range of antisera produced was small but novel and of a very high quality, leading to numerous requests for material from Immunology groups around the world. During the ensuing years the range of antibodies grew rapidly and in the early 1980's a commercial immunodiagnostic company, Binding Site, was founded.
Expertise in immunisation and processing techniques has enabled us to build a range of immunodiagnostic products aimed at fulfilling the needs of commercial and government funded laboratories in a range of markets - Hospitals, Reference Centres, Universities, Pharmaceuticals, Therapeutics - whatever their size or complexity.
Innovative new products and improved product performance are the benefits of our collaborations with numerous centres of excellence, coupled with a highly professional scientific and technical manufacturing staff.
Our product portfolio has grown to include the most comprehensive range of assays for Primary Immunodeficiency in the world. We have also been able to develop the Freelite assays, the first nephelometric tests for measuring free immunoglobulin kappa and lambda light chains in serum. These assays give a sensitivity, accessibility and consistency never before achievable, allowing significant improvements in laboratory and clinical practice for the detection and monitoring of B cell malignancies. Rigorous quality assurance procedures help ensure that we provide only products of the very highest standard and with technical support and educational programmes offered world-wide we are able to offer all of our customers the benefits of our technical expertise and knowledge. Website: www.bindingsite.com

BIOCRATES Life Sciences AG

BIOCRATES Life Sciences AG is a leading biotechnology company focused on biomarker discovery and development of diagnostics for early disease detection (nephrology, diabetes) and companion diagnostics. BIOCRATES` unique targeted metabolomics platform enables a quick and cost effective way of identification and quantification of a broad range of endogenous metabolites in different body fluids and tissues. BIOCRATES sets the standard for targeted metabolomics by providing the most trusted and comprehensive research kits and IVDs for assessing disease, as well as understanding drug, food, and environmental effects.
Biomarker Diagnostics: Biocrates works on the identification, validation and commercialization of metabolic biomarkers for diagnostic products developed in house or with strong partners. Biocrates focuses on indications with high medical need and attractive commercial potential, e.g. cancer, chronic kidney nephropathy or metabolic syndrome/Type II diabetes.
TargetIDQ™ Services: Contract research services supports customers in identifying and quantifying hundreds of metabolites from a broad range of samples, ultimately revealing meaningful biomarkers.
AbsoluteIDQ™ Kits: In 2008 the first metabolomic kit of its kind was launched which enables quick, accurate detection and quantification of over 180 metabolites from four classes from only 10 microliters of plasma. 
MetaDisIDQ™ Kit: The MetaDisIDQTM Kit is part of a new generation of research diagnostic tools providing metabolomics information that allows a comprehensive assessment of a person's metabolic state.
SteroIDQ Kit: The Kit offers a unique experience in standardized, quantitative steroid hormone detection by simultaneously analyzing (multiplexing) 16 different steroid hormones with tandem mass spectrometry (LC-MS/MS).
Website: www.biocrates.com

Bio-Rad Laboratories

Founded in 1952, Bio-Rad has its headquarter based in Hercules, California. It has remained at the centre of scientific discovery for more than 50 years by providing a broad range of innovative tools and services.
Bio-Rad employs more than 6,800 professionals worldwide within a network of more than 30 wholly owned subsidiaries serving more than 150 countries. Its two primary businesses include Clinical Diagnostics and Life Science research.
Bio-Rad serves more than 100,000 research, industry and clinical laboratories around the globe. It is world renowned within its core industry segments with customers in hospitals, universities, research institutions, microbiological and environmental inspection agencies, pharmacological and biological research and private industry laboratory.
Bio-Rad is the number one specialty diagnostics company. It holds leadership positions in quality control management, diabetes monitoring, blood virus testing and detection, blood typing and autoimmune disorders testing
Website: http://www.bio-rad.com/

Care S.r.l.

Care S.r.l. is an Italian Company dealing with the manufacturing and distribution of in vitro diagnostic devices and development and management of Internal and "External Quality Assessment Schemes" (EQAS) and Internal Quality Control (IQC) profiles for Laboratories all over Italy. Originally, Care was focused on the production and development of Laboratory immunodiagnostics, specializing in infectious diseases as development of reagents for the diagnostics of Hepatitis and  HIV . In 1992 has focused its activity on the production of a complete line of ELISA Immunodiagnostics on microplate for Hepatitis B and  Torch Group Diseases, starting to sell these products all over Italy and the world. As far as this activity is concerned, in 1993, CARE achieves the registration of the IVD Supermik (HbsAg ELISA kit) at the Italian Department of Health. Subsequently Care focuses on the organization of External Quality Assessment Schemes (EQAS), which it supplies all over Italy. Care has always oriented its productive and development activities to GMP and in June 24, 2004 Care certified its own Quality System, according to UNI EN ISO 9001:2000 and from 2007 UNI EN ISO 13485:2003 having the following subject: "Design and manufacture of in vitro diagnostic reagents, internal quality control (IQC) materials and external quality assessment (EQA) schemes"
Website: http://www.dicocare.org

C.P.M. Diagnostic Research SAS

Since 1986 we have been involved in hospital sanitation projects both in Italy and abroad promoted by the Cooperazione Italiana, the European Union and the Vatican Foreign Mission. Our teamwork attitude has gained us loyal customers in the construction industry, oil industry (Agip Recherches) and ONG, the Italian Red Cross, in the construction of hospital and medical centers, like the hospital in Quelimane in Mozambique, the hospital in Sidone Lebanon, the hospital in Thaoua and Zinder in Niger, the San Juan de Dios hospital in Colombia and pharmaceutical products, diagnostic material, medical supplies and hospital facilities to Bosnia, Sierra Leone, New Guinea, Haiti, the Ukraine, Angola, Guatemala, Tanzania and other countries as part of programs operated by the E.C.H.O and EU program.
On behalf of the United Nations and in collaboration with LIFE Rome, we built a totally solar powered mobile health-care unit wich was been to Salvador.
To K.P.O - Karachaganak Petroleum Operating - B.V. have been supplied emergency and intensive care ambulances where these vehicles were able to offer their service above where the climatic conditions and temperature are exesperated (+50°C / -38°C).
Moreover, since 15 years, C.P.M. SAS have a branch office in the Rupublic of Cuba recognized by the local government and where we are one of the most important distributor in Chemical Chemisty and Microbiology sector with a wide range of products registred near the local Health Authority.
C.P.M. SAS thanks to its efficiency in quality and manufacturing process have obtained the ISO 9001:2008 and ISO 13485:2004 certifications.
Website: http://www.cpmsas.it/ 

Dako A/S

The Dako Group develops, manufactures and markets products and complete systems that assist medical research and diagnostics in the fields of tissue-based cancer diagnostics, specific proteins and flow cytometry.
Within specific proteins, Dako specializes in the quantitative determination of proteins in body fluids, such as plasma/serum, cerebrospinal fluid and urine. Based on many years of dedicated research, Dako has successfully developed optimized test systems for turbidimetry/nephelometry - some based on the more sensitive technique of particle-enhanced turbidimetry. The portfolio of turbidimetry/nephelometry assays covers the areas of kidney, cardiovascular risk and patient profiling. Protein standardization has always been important for Dako and participation in international standardization committees has brought Dako in the front-line of international protein standardization, particularly through the work of Søren Blirup-Jensen, DVM, PhD.
The flow cytometry portfolio counts more than 200 CE-IVD-labeled reagents. Furthermore, the MultiMixTM color panels for immunophenotyping of leukemia and lymphoma provide a guideline for identification of hematological malignancies with a limited number of antibodies.
Website: www.dako.com

DiaSys Diagnostic Systems GmbH

DiaSys Diagnostic Systems is a leading specialist in development and manufacturing of diagnostic systems of high quality combined with ease of use and reduced environmental burden.
Focusing on clinical chemistry and immunoturbidimetric tests DiaSys introduced more than 80 optimised reagents for routine and special diagnostics in user-friendly kits for manual or automated use. Additionally, the programme includes a broad range of appropriate calibrators and controls.
The analytical instrumentation portfolio comprises automated clinical chemistry system analyzers, semi-automated analyzers, POCT instruments for diabetes as well as glucose/lactate analyzers. The instrument line is completed by reverse osmosis systems for purified water.
DiaSys is an ISO certified company since 1996 (valid certificates ISO 13485:2003, ISO 9001:2000). To date, customers and partners in more than 100 countries around the world rely on DiaSys quality.
Website: www.diasys-diagnostics.com

Diatron

Diatron specializes in the development, manufacturing and marketing of hematology analyzers, reagents (both for our own and other manufacturers' analyzers) and hematology control material as well as clinical chemistry analyzers, clinical chemistry reagents and controls for human medical and veterinary use.  The brand name of Diatron has been established throughout the world as a result of our capability for manufacturing high quality and extremely reliable instruments, which has resulted in our products being sold and marketed in more than 100 countries. Today, there are more than 30,000 Diatron clinical chemistry and hematology analyzers in laboratory use, and our customer base continues to grow strongly year after year. All of our products have CE marking with some having FDA clearance, thus allowing sale to the USA market.
Website: www.diatron.com

Drew Scientific Co. Limited

Drew Scientific designs, manufactures and sells a range of analytical instrumentation for clinical chemistry and haematology laboratories in both human and veterinary medicine. The company operates from three sites in Texas, Connecticut and England. Drew has distributors in 150 countries.
The company's chemistry product range includes analysers for glycated haemoglobin, haemoglobinopathies and blood chemistry. For haematology the company has a range of systems for human, veterinary and research use, offering five part white cell differential counting and as many as 30 different species.
Both ranges of analysers are backed by a comprehensive range of reagents, calibrators and controls. Drew Scientific is a wholly owned subsidiary of Escalon Medical Corporation Inc.
Website: http://www.drew-scientific.com

ELGA LabWater

ELGA is an integral part of Veolia Water Solutions and Technologies, the world leader in water treatment. Veolia Water Solutions and Technologies has a global revenue of 2.5 billion Euros and worldwide team of 9,500 employees. It is renowned for its capabilities in providing water solutions of any size to customers throughout the entire water cycle.
Our commitment to developing and providing purified laboratory water means that you can focus on obtaining accurate results. We specialise in the following markets:

  • Research and Testing
  • Healthcare
  • Clinical Diagnostics

All systems are manufacture in the UK and we are accredited to ISO9001 and ISO14001 standards. We have our own R&D facilities and are always looking to provide products dedicated to providing the right water quality for your application.
ELGA focuses exclusively on water and its treatment. We continually contribute to the unique technical and scientific applications expertise developed during the last 50 years. ELGA is experienced in meeting the challenges that arise during the development, installation and servicing of single point-of-use purification systems as well as large projects involving consultation with architects, consultants and clients.
Website: http://www.elgalabwater.com/home

Fujirebio Europe

Fujirebio is a leading international healthcare company with a strong focus on high qualityin vitrodiagnostics testing solutions. Founded over 60 years ago, the company is recognized as the world-wide leader in oncology for both routine and novel markers and has a strong reputation in Japan within infectious disease testing in hospitals, clinic labs and blood banks. Over the last 20 years Fujirebio has been successfully marketing automated immunoassay testing solutions and has, under the  name Innogenetics (now Fujerebio Europe), pioneered the field of molecular diagnostics and multiparameter testing. It is today among the world-leaders in strip-based diagnostics solutions.
Website: www.fujirebio.europe.com

 

Gentian AS

Gentian is a privately held company with products and patent protected technologies for chemical analysis of human and veterinary samples.
Gentian's tests are based on particle enhanced turbidimetry and nephelometry. Focusing on precise measurements of kidney function, Gentian has become a leading force in introducing the novel renal marker Cystatin C in routine diagnostics in clinical laboratories worldwide. Superior to serum creatinine, MDRD and invasive renal diagnostic methods, Cystatin C is also an early risk marker for cardiovascular disease.  However, the potential of this marker is dependent on a strong assay signal. The technology of enhancing assay signal strength is Gentian's market advantage.
Gentian is situated in Oslo, Norway and Beijing, China. Valid certificates include ISO 13485:2003 and ISO 9001:2000.
Website: www.gentian.no

 

Guangzhou Wondfo Biotech Co. Ltd.

Guangzhou Wondfo Biotech Co. Ltd. was founded in 1992 as a research based company in the campus of South China University in Guangzhou, Guangdong Province, China. In 2010, Wondfo moved to a new site which locates at Scientific City, Luogang Distrcit, Guangzhou. The Operation quickly grew beyond research purpose towards manufacturing of quality medical products and biochemical reagents, in particular the point-of-care testing kits and devices.  Wondfo has obtained ISO 13485:2003 certificate. Its products have been cleared by the US FDA, Chinese FDA and received CE Mark.
Website: www.wondfo.com.cn

 

Hytest Ltd.

HyTest Ltd., founded in 1994, offers innovative solutions for assay development and research applications by providing high-quality immunological reagents in such areas as cardiac markers, infectious, neuroscience, biological warfare agents and autoimmune disease reagents. HyTest is a leading provider of several reagents such as antibodies and antigens of the troponin I, troponin complex and Influenza A and B. HyTest offers also extensive customer services and has a certified ISO 9001:2000 quality system.
Website: www.hytest.fi

Instrumentation Laboratory

Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include Critical Care systems, Hemostasis systems and Information Management systems. IL's GEM®  product offerings, part of the Critical Care line, include the GEM Premier™ 4000 analyzer with Intelligent Quality Management (iQM®), GEM Premier 3500, GEMweb® Plus Custom Connectivity, and complimentary products GEM PCL Plus, a portable coagulation analyzer the ACL TOP® Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the ACL TOP 700, ACL TOP 700 LAS, ACL TOP 700 CTS, ACL TOP 500 CTS and ACL TOP 300 CTS. IL also offers the ACL AcuStar®, ACL ELITE®, other Hemostasis analyzers and the HemosIL® line of reagents. IL is based in Bedford, Massachusetts.
Website: www.ilus.com 

Labquality

Labquality is an impartial organization owned by Hospitals and associations. The aim of External Quality Assessment Schemes (EQAS) is to improve quality in clinical laboratories by supplying data to the laboratories on their performance compared with other laboratories. Labquality is a member of EQALM (External Quality Assessment in Laboratory Medicine) and cooperates with other EQA organizers in Europe.
Website: http://www.labquality.fi/in_english/

A. Menarini Diagnostics

Born as a division of pharmaceutical A. Menarini Industrie Farmaceutiche Riunite, headquartered in Florence and with over 13.000 employees in 70 countries, A. Menarini Diagnostics is a health care company  with more than 30 years of experience in developing and leading the European market of prevention and focused on diagnostics.  For the European healthcare community we are a dynamic and reliable partner providing innovative diagnostic solutions thanks to our deep relation with the market, and therefore, knowledge of its needs. 
All therapy decisions are based on reliable informed diagnosis as well as quality of life is related to prevention. These are the main reasons for our daily committed work. By focusing on well-defined and selected diagnostic areas, we create value for the society as a whole. Extensive investments in research, strategic alliances, and a constant, close, and intelligent presence into the healthcare community, allow us to be a leading European company and a trustful partner for both patients and professionals. Our aim is to make diagnostics management easier, more effective and result cost efficient.
All over Europe each client can be supported by one of our more than 700 skilled scientific consultants. In fact we are one of the diagnostics company with the most capillary presence in Western Europe covering with our own network 90.3% of the population and serving a market of 300 millions people. We have 13 fully owned subsidiaries, and in the future we will establish our presence also in East and North of Europe. We have a leading position in the Diabetes monitoring and our activities also cover Urinanalysis, Autoimmune diseases, Hematology, Immunology, Immunohistochemistry, Wet and Dry Chemistry systems.
Website: www.menarini.com

Merck Millipore 

Overview
Merck Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science. Headquartered in Billerica,Massachusetts, Merck Millipore has around 10,000 employees, operations in 67 countries and 2010 revenues of EUR 1.7 billion. Merck Millipore operates as EMD Millipore in the U.S. and Canada.

Pure water expertise for biomedical laboratories
With over 50 years of experience in laboratory water purification and an installed base of more than 100,000 water purification systems worldwide, our long history of collaboration with biomedical laboratories has enabled us to develop our expertise concerning biomedical applications as well as water purification technologies. Merck Millipore offers a complete range of water purification systems designed to match the needs of small through large volume applications. Compatible with any analyzer, these direct-feed systems are economical, easy to use, save water and improve productivity and results. Our portfolio includes the AFS®, Elix®, and Elix® Gulfstream Clinical product ranges.
For more information please see our website: http://www.millipore.com/labwater 

Mindray

Mindray was founded in 1991 with the goal of delivering high-quality, competitively priced medical devices to make healthcare more accessible and affordable around the world. In 2006, Mindray listed on the New York Stock Exchange.
The company has three well-established business segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products and Medical Imaging Systems. Health care facilities equipped with Mindray's products can be found in over 190 countries and regions. The IVD Mindray has a global R&D network with research centers in Shenzhen, Beijing, Nanjing, Seattle, New Jersey and Stockholm. Approximately 10% of total revenue has been consistently re-invested into R&D each year. An average of eight new products has annually been introduced to the market over the past seven years. The detail information please visit our web site: www.mindray.com

Mitsubishi Chemical Europe GmbH

Mitsubishi Chemical Medience is a subsidiary of Mitsubishi Chemical Corporation. For more than 40 years now, it provides biological and medical/clinical labs with fast and highly precise analysis methods from its extensive and continuously expanded test portfolio.  The outstanding quality of its appliances, reagents and service are the basis and the future perspective of the Japanese cooperation with its decades-long success story. Already back in 1982, Mitsubishi Chemical Corporation was the first company worldwide to develop the LPIA (latex photometric immunoassay) method to market maturity. Latest innovative product is PATHFAST® a fully automated chemiluminescence immuno anaylser platform for the determination of biomarkers for fast differential diagnosis in central labs and at the point of care. The Mitsubishi Chemical Medience Group  is aiming for further development under the management vision of "Good Health Creator, MEDIcal+sciENCE: Creating a Healthy and Safe Society through Medical Science." Its core business today comprises the development, production and distribution of analysis devices and reagents sets based on the patented LPIA technology on the one hand, and a significant engagement in the "theranostics" sector on the other.  In this sector, the company maintains global connections and cooperations with research companies and internationally operating university factories and labs today. Its major focus on research will also guarantee products with the highest possible state of development in the future. Mitsubishi Chemical Europe GmbH is the representative of  diagnostic business in EMEA.
Website: www.mitsubishichemical.com

Nova Biomedical Corporation

Nova Biomedical's clinical laboratory business comprises point of care ivd test systems used in hospital and primary care settings. These include innovative new hand held point of care sensors as well as an array of blood gas and critical care analysers offering a wide menu range.
Website: http://www.novabiomedical.com/

Oneworld Accuracy Collaboration

We invite leading clinical and research groups around the world to become Science Architects in the Oneworld Accuracy Collaboration. We embed their science in programs that assess, improve and standardize test results. We add those programs to OASYS - Oneworld Accuracy System. OASYS is an online system that can connect anyone in the world that has Internet access. We invite national groups to own the challenge of achieving testing accuracy in their countries. We empower them as Collaboration Members. We give them the tools they need: programs, online system, training and the collective experience of their Collaboration peers. We invite laboratories, doctors, clinics and pharmacies to participate in our EQA and Standardization programs. Oneworld Accuracy currently has 30 Collaboration Members who provide 25,000 program subscriptions every year to 5,000 participants in 55 countries.
Website: oneworldaccuracy.com

Ortho-Clinical Diagnostics, Inc.

Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, delivers the high quality in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner.  The company serves the global transfusion medicine community with donor screening and blood typing products to help ensure every patient receives blood that is safe, the right type, and the right unit.  Ortho Clinical Diagnostics also brings sophisticated information management, testing technologies, automation and interpretation tools to clinical laboratories worldwide to help them run more efficiently and improve patient care. 
For more information, visit: www.orthoclinical.com

Philips

At Philips, we try to simplify healthcare through combining our unique clinical expertise with human insights to develop innovations that ultimately help to improve the quality of people's lives.
With a growing presence in cardiology, oncology, and women's health, we focus on the fundamental health problems with which people are confronted, such as congestive heart failure, lung and breast cancers and coronary artery disease. Our focus is to deliver value throughout the complete cycle of care: from disease prevention to screening and diagnosis through to treatment, monitoring and health management. Philips is dedicated to making an impact wherever care happens, within the hospital - critical care, emergency care and surgery - and, as importantly, in the home.
Philips Handheld Diagnostics focuses on developing innovative solutions to revolutionize point of care testing with a fully-automated rapid diagnostics testing platform that will deliver lab-equivalent test results at the point of care - within minutes.
Website: www.philips.com/magnotech

PPD Inc.

PPD is a leading global contract research organization providing drug discover, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. PPD laboratories including the Central Clinical Laboratories (US, Belgium, Singapore and China), Bioanalytical laboratories (VA. and WI) and Phase 1 Unit Clinical Laboratory (TX) provide a wide array of clinical laboratory testing services for clinical trial patients and bioanalytical assay development and specimen analysis in support pharmaceutical drug research and development.
Website: www.ppdi.com

Radiometer Medical ApS

Radiometer is a leading provider of technologically advanced solutions that simplify and automate all phases of acute care testing. Radiometer offers solutions for blood gas analysis, immunoassay testing and transcutaneous monitoring.
By providing fast and accurate acute diagnostic results, healthcare professionals can make immediate and well-informed decisions that enable them to improve patient care and optimize patient flow in all acute care settings - intensive care units (ICUs), emergency departments (EDs) and operating rooms (ORs).
Founded in 1935 and headquartered in Copenhagen, Denmark, Radiometer was a pioneer in blood gas testing, introducing the world's first commercially available blood gas analyzer in 1954. A long series of new product platforms have been developed since then making Radiometer the 'gold standard' in blood gas analysis.
Also today, Radiometer is focused on innovation and invests heavily in research and development of new and improved acute care solutions that enable fast and accurate diagnosis and treatment of critically ill patients.
At Radiometer, we pride ourselves on having both international scope and local reach, closely supporting entire multi-hospital networks, individual hospitals and small community clinics in over 100 countries around the world.
For more information about blood gas analyzers, immunoassay analyzers or transcutaneous monitoring solutions, visit www.radiometer.com.
For information about the latest trends in acute care testing, visit www.acutecaretesting.org, Radiometer's knowledge site.

Randox Laboratories Ltd.

Randox Laboratories, a market leader within the in vitro diagnostics industry, has 30 years experience in developing and manufacturing high quality products for laboratories worldwide. Our extensive product portfolio offers complete solutions within the fields of clinical chemistry, forensic toxicology, veterinary, drug residues, life sciences, oncology, molecular diagnostics and internal and external quality control.
Our innovative approach to diagnostics has enabled the development of a wide range of products including our benchtop clinical chemistry analysers, the RX daytona, RX imola and RX monza. The advanced functionality of each analyser ensures outstanding flexibility, optimum reliability coupled with a comprehensive test panel and cost saving features. The most recent addition to the RX series, the RX suzuka, offers high quality testing for the larger throughput laboratory.
Randox has also developed a full range of immunoassay analyser systems. The Evidence family of analysers include the Evidence, Evidence Investigator, Evidence MultiStat and Evidence Evolution. Each system incorporates revolutionary Biochip Array Technology that allows simultaneous detection of multiple analytes from a single patient sample. Rapid effortless testing, advanced consolidation and high quality results are a few of the many benefits of the Evidence analysers. The extensive biochip test menu includes both protein and DNA biochips, expanding the range to over 215 different biomarkers.
Our goal is to 'revolutionise healthcare through continuously improving diagnostic solutions'. We continue to achieve this year after year due to our commitment and significant re-investment in Research and Development. Our large support network of staff allows us to develop and perfect revolutionary products, specifically designed to provide more efficient, higher quality and reliable results, ensuring patients receive the right diagnosis at the right time.
Website: www.randox.com

Response Biomedical Corporation

Responde Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP® platform for clinical and environmental applications. RAMP® represents a new paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use. The RAMP® system consists of a Reader and single-use disposable test cartridges, and has the potential to be adapted to more than 250 medical and non-medical tests currently performed in laboratories. RAMP® clinical tests are commercially available for the early detection of heart attack and congestive heart failure.
For more details please visit the website: http://www.responsebio.com/

Roche Diagnostics GmbH

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients.
In 2008, Roche had over 80,000 employees worldwide and invested almost 9 billion Swiss francs in R&D. The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

Scipac Ltd.

SCIPAC provides a wide selection of human proteins, disease plasma and depleted serums and antibodies for the worldwide clinical diagnostics manufacturers.
Diagnostics assays are a major component of modern medical examination and many hospital laboratories across the world use diagnostics kits containing SCIPAC components. With "Raising the Standard" as a key pursuit they have ISO 9001 and 13485 registration and a constant striving for better standards of production and customer service.
This is appreciated by SCIPAC customers and reflected in the company's expansion and reach. Their products are now used by assay manufacturers in over 30 countries with 60% of sales to the USA. Sales expansion in both bulk sales and increased product range have meant steady growth with sales have doubling in the past three years. The aim of the founders to provide the complete SCIentific PACkage has been fulfilled very successfully.
The link with academia has always been highly valued and has been expanding over the past few years. Sunny-Lab.com is a new business venture which enables the researcher to obtain smaller packages by direct credit card purchase. This e-commerce site also encourages academics to share information and get feedback on their work. An exciting new venture for a visionary, outward looking company.
SCIPAC is situated at Sittingbourne, 40 miles southeast of London.
Website: www.scipac.com

Sebia S.A.

Develops, manufactures and commercializes protein electrophoresis tests and analyzers, dedicated to the in vitro diagnosis of cancer, inflammatory, metabolism and hemoglobin disorders. SEBIA's focus on electrophoresis techniques, allows a sustained R&D program, providing to any type of labs access to genuine evolution. Both agarose gel and capillary assays and their dedicated automation are designed to be integrated into the same routine workflow, for gel (ASSIST, HYDRASYS™ 2) and for capillary electrophoresis, (CAPILLARYS™ 2, MINICAP™). SEBIA has recently diversified its activity by introducing Capillarys 2 Flex Piercing, the most advanced capillary technology, providing high level of performance, bringing complete walk-away automation. Tests available are serum proteins, urine proteins, Immunotyping, high resolution electrophoresis, CDT, and haemoglobinopathy screening from whole blood in primary capped tubes. Recently, SEBIA has diversified its activity in the field of diabetes, to fulfill the growing worldwide demand for more accurate and reproducible methods for HbA1C measurement.
Website: www.sebia.com

Sekisui Diagnostics (UK) Ltd.

In 2011 Sekisui Diagnostics was created from the acquisition of Genzyme Diagnostics by Sekisui Chemical.
We offer a unique product portfolio for diagnostic manufacturers and healthcare professionals worldwide, comprising of Critical Raw Materials, Clinical Chemistry Reagents, and Point of Care Rapid Tests.
Our competency in microbial fermentation, purification, and reagent formulation allows us to supply more than 50 intermediate products to clinical chemistry manufacturers and over 60 formulated reagents to chemistry instrument manufacturers and clinical laboratories worldwide. These portfolios are focused on diagnostic solutions for Cardiovascular disease, Diabetes, and Renal disease.
Our OSOM® branded Rapid Tests for infectious diseases and women's health are developed for use in the point-of-care setting, designed to help physicians quickly and accurately diagnose their patients in order to provide the most appropriate treatment.
Sekisui Diagnostics also has active research programs in a variety of different clinical areas.
Website: www.sekisuidiagnostics.com

Sentinel CH. SpA

Sentinel CH SpA  is an Italian company founded in 1983.
For over twenty years Sentinel has been committed to the development of innovative IVD devices in the bid to make clinical diagnosis ever more reliable.
In 2006 Sentinel moved to new high-tech premises covering a total area of about 10.000m².
The company is ISO 9001:2000, ISO 13485:2003 and ISO 13485:2003 CMDCAS certified.
Sentinel is compliant with the European Directives (98/79/CE), 21C CFR 820 "Code of Federal Regulations" FDA (U.A. Food and Drug Administration), SOE-98-282 (Canadian Medical Devices Regulations) as well as with directives of other countries, including Canada (CMDCAS). The facility, equipments and Quality System are regularly audited by Certification Body, Registrar Body and by customers and inspected by the National Competent Authority and FDA.
Sentinel's commitment to comply with IVD regulations has facilitated and supported successful partnerships in the industry as well as the distribution of Sentinel's products in over 70 countries worldwide.
Sentinel has an active presence at the major international congresses, presenting posters written by its specialised scientists. Sentinel is an active partner of IRMM projects for the release of new References Preparations for proteins.
The Technical and Manufacturing departments count for 70% of the company.
More than 100 different assays, under our own brand and also as customized kits, are manufactured in contamination-free clean rooms (ISO 8 and ISO 7 qualified).
The company's main areas of activity are:

  • Clinical Chemistry
  • Immunoturbidimetry
  • Calibrators, controls
  • Fully automated systems for Clinical and Immunochemistry, Fecal Occult Blood (FOB) testing and Coagulation.

The new Molecular Biology department initiated in 2008 has its own Production clean rooms (ISO 7) as well as R&D laboratory.
Sentinel Diagnostics: "Watching over Life"
Website: www.sentineldiagnostics.com

Shanghai Zhicheng Biological Technology Co.,Ltd

Shanghai Zhicheng is an innovative Chinese company devoted to manufacturing and marketing in vitro diagnostic (IVD) tests for use in clinical laboratories. We have been focusing on promoting the quality of our products by serious and pragmatic R&D, strict QC according to ISO 13485 and ISO 9001 since the company was founded by Mr. Wanghui in 1995. Now our products were distributed more than 1000 laboratories in China with famous brand of DENUO.
Website: http://www.shzhicheng.com

Sichuan Maker Biotechnology Co., Ltd.

Sichuan Maker Biotechnology Co., Ltd. is one of the largest companies specialized in manufacturing clinical diagnostic products in China.
MAKER was incorporated in Nov. 1994, since its inception, MAKER focuses on the production of quality diagnostic products through dedicated R&D, strict QC, and advanced manufacturing processes. Now, over 100 SFDA licensed diagnostic products are manufactured and marked throughout China.
Over a decade, MAKER always insists in technology innovation for sustainable development, and has been transformed into one of the leading IVD companies in China.
Website: www.china-maker.com

Siemens Healthcare Diagnostics

Siemens Healthcare Diagnostics provides healthcare professionals in hospital, reference, and physician office laboratories, and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor patients. The company's innovative portfolio of performance-driven solutions and personalized customer care combine to streamline workflow, enhance operational efficiency, and support improved patient outcomes.
The company serves 30,000 customers in more than 120 countries and offers solutions for immunoassay, chemistry, automation, hemostasis, hematology, blood gas, diabetes, urinalysis, microbiology, and molecular testing, and also offers a comprehensive diagnostics IT portfolio. As a global leader in clinical diagnostics, Siemens' forward-thinking products and services are helping clinicians deliver better care so people around the world can lead healthier lives.
To learn more about Siemens Healthcare Diagnostics, please visit our Web site at www.siemens.com/diagnostics

Snibe Co., Ltd. (Shenzhen New Industries Biomedical Engineering)

As a leading company in medical equipment field in China, since 1995, Snibe started the research & development on immunology solution and always keeping focused on it. With this strategy, Snibe dedicated to develop, manufacture and provide an extensive range of automated immunoassay solution to hospitals, medical centres, clinical laboratories etc.
The successful launch of automated chemiluminescence immunoassay system, MAGLUMI series, is a great milestone of SNIBE's product development. Based on flash chemiluminescence and microbead separation technology, MAGLUMI system provides a comprehensive test menu and variety analyzers as a complete solution for laboratories' immunoassay demands. A module system, including ISE, biochemistry and immunoassay, is going to be launched soon. The next great step for Snibe will be extending immunoassay to IVD area.

Sonic Healthcare Europe

Sonic Healthcare is an international healthcare group focused on delivering quality, independent services in medical diagnostics worldwide. In eight countries across three continents, the company is structured as a decentralized federation of medically-led practices. Sonic Healthcare operates in three key segments: pathology which includes pathology/clinical laboratory services provided in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, Belgium and Ireland; radiology, which include radiology and diagnostic imaging services provided in Australia and New Zealand, and other, which includes the corporate office function, medical centre operations (IPN) and other minor operations. Sonic Healthcare employs approximately 26,000 people with its head office located in Sydney, Australia.
Web site:http://www.sonichealthcare.com/

Sysmex Europe GmbH

SYSMEX EUROPE GMBH, Germany-based daughter company of SYSMEX CORPORATION, Kobe, Japan, is responsible for customer and sales support for Sysmex's in vitro diagnostic systems and reagents as well as manufacture and sales of reagents for Sysmex's in vitro diagnostic systems in the European, African and Middle East markets.
Sysmex, a manufacturer of comprehensive clinical testing, is engaged in clinical laboratory testing of blood, urine and other specimens, covering the areas of haematology, haemostasis, immunochemistry, biochemistry, urinalysis and faecal occult blood testing.
In the field of haematology, Sysmex holds the global market leader position. In addition to providing instruments and reagents for clinical laboratory testing, Sysmex is also developing a broad range of laboratory information systems and application software, thus offering information technology as part of its comprehensive service and support system. Integration of those various technologies is the driving force behind Sysmex's business activities.
Sysmex is also developing these technologies and expertise to expand its areas of business. For example, it is expanding into such fields as point of care (POC) testing - clinical laboratory tests conducted on the spot, such as in the hospital operating room, intensive care unit, or at the clinic - to enable faster diagnoses, centralized test data management for improved testing efficiency, and the establishment of local healthcare networks to link hospitals and clinics.
At the same time, Sysmex is also creating new core technologies to address the challenges of disease prevention and early cancer detection.
By expanding its business into these healthcare testing fields, Sysmex intends to contribute to the creation of a vibrant and healthy society. In addition, Sysmex is applying the technologies that it has devised in the field of clinical laboratory testing to industry, sports, and other new business fields.
At Sysmex, we have adopted two commitments to the future: to continually develop advanced technologies and create value with the aim of serving our customers and society at large; and to play a key role in contributing to the health and vitality of people the world over. It begins with close attention to the voices of our customers.
Website: www.sysmex-europe.com

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. We have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.
Website: http://www.thermofisher.com/

Unilabs

Unilabs is a leading clinical European supplier of laboratory medicine and radiology services with operations in 12 European countries.
Unilabs supplies diagnostics services to:

  • Public and Private healthcare units
    • Hospitals
    • Outpatient clinics
    • GPs
    • Occupational health units
  • County councils
  • The general public
  • Insurance companies

Unilabs also provides Laboratory and Logistics services for drug development companies & CROs.
Website: www.unilabs.com

Wako Pure Chemical Industries, Ltd./Wako

Wako Pure Chemical Industries, Ltd. is a leading provider of clinical chemistry reagents and systems. Since 1922, Wako has devoted itself topioneered the research, development, and manufactureing of high quality reagents since 1922. Headquartered in Osaka, Japan, Wako is an, becoming a international global in vitro diagnostic company with research, manufacturing, and sales offices and marketing in Japan, the United States and Germany. Wako is committed to the development of novel diagnostic and research reagents in the life sciences. Through intensive studies in clinical chemistry, immunoassay and microfluidics, Wako keeps abreast of the latestprovides state-of-the-art diagnostic developments in medical science, systemsin order to develop products tailored to the sophisticated requirements of our clients in various medical fields. Wako has developed a wide range of liquid chemistry reagents designed for use in the clinical laboratory. They include innovative reagents assays that use microfluidics (AFP-L3% and des-carboxy Prothrombin), liposome technology, the reagent for total complement activity (CH50), and the a micro-organism detection system using LAL and SLP to detect endotoxin, glucan, and peptidoglycan. Wako provides advanced assays for Free Fatty Acid (NEFA), enzymatic Creatinine, hyaluronic acid, as well as superior reagents for standard clinical chemistry analytes.. Wako has a consistent focus on the development of new and important tests for the diagnostic community. For example, Wako now provides a test that includes both novel chemistry and instrumentation for the measurement of AFP-L3%, a test that will improve the chances for finding liver cancers at an earlier and more treatable stage. Recently, Wako has also introduced a bench top clinical analyzer that utilizes many of these chemistries at the point of care in the physician's office, bringing the value of testing closer to the patient. As one of the industry's leading pioneers, Wako will continues to develop and supply chemicals, reagents, and instruments of the highest quality to meet the growing and changing needs of the diagnostic and research communities.
Website: www.wako-chem.co.jp

Wiener Lab

Wiener lab. develops, manufactures and markets FDA approved diagnostic reagents since 1960. It is also the distributor of technical equipment from international renowned companies. It is located in Rosario, Argentina, in a crossroads of the Mercosur. It is the leading manufacturer of diagnostic reagents in Latin America and its sales network includes six associated companies in Brazil, Chile, Colombia, Mexico, Peru and Venezuela, and has sales representatives in the other countries of the region. Its exports operations for Eastern Europe and the Middle East are performed through its associate company Wiener lab. Switzerland. Wiener lab. products are focused on clinical analysis and specialised hospital laboratories. Its products are based on the research, development and production of monoclonal antibodies to manufacture several tests: Hepatitis, Pregnancy, Blood Typing; production and purification of antigens for the detection of parasitic (Chagas'disease, Toxoplasmosis), bacterial (Brucella, Salmonella) or viral (Hepatitis, AIDS) diseases; applied research on recombinant nucleic acids and nucleic acid probes, as well as PCR (Polymerase Chain Reaction) procedures; design of recombinant proteins and synthetic peptides with antigenic activity; and research on different branches of Biotechnology. The leading edge technology in the research and development of diagnostics kits for Chagas'disease have earned Wiener lab. an outstanding position within the diagnostic market.
Some of Wiener lab. products are the result of joint projects with renowned research centres. Along with the Program for Appropriate Technologies in Health (PATH-Seattle, USA), Wiener lab. has developed a high sensitivity, non-instrumental procedure for HIV carriers screening, the D.I.A. (Dot Immuno Assay) HIV 1+2, which has been evaluated and approved by the World Health Organisation. Wiener lab. keeps up to date in scientific research and manufacturing technologies in order to improve and develop products of advanced technology.
Website: www.wiener-lab.com.ar

 

Wisplinghoff Laboratoriumsmedizin Köln

Wisplinghoff diagnostic services are backed by a strong team of 29 medical doctors and scientists in Cologne.
contribute to the overall progress of healthcare by leading collaborations with industry and academic institutions in order to develop new techniques, carry out research and promote synergies between our scientists, academics and colleagues in the industry.
Website: http://www.wisplinghoff.de/en



 

 

 

Site udviklet af Insoft Digital